After analyzing financial data of nine publicly traded labs from the first quarter of 2008, Washington G-2 Reports finds that Psychemedics (Acton, Mass.), had the highest revenue per full-time employee (FTE) with $60,638, which is essentially the same as the Q1 2007 value, as the company’s revenue over that time period has remained flat. With 97 FTEs, Psychemedics performs drug-of-abuse testing through corporate and school programs. Psychemedics also led in both benchmarks in G-2’s analysis of 2007 data (LIR, May 2008).

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

June 2008 - Table of Contents

LIR June 2008 (full PDF issue)

Prices Dropping on Some DTC Genetic Tests as SACGHS Urges Tighter Regs

G-2 Predicts Global Mol Dx Industry to Reach $5.5 Billion in 2008, $8 Billion by 2010

Quest, LabCorp Revenue/Requisition Metrics Strengthen in Q1

LabCorp’s Partners With Siemens, Acquires Louisiana Lab

Cost and Profit Analysis Is Key to Capturing Revenue Potential of Mol Dx Lab

Q1 08 Lab Benchmark Data Reveal Psychemedics Still a Leader, Enzo Posts Gains

JVHL Teams With Clarient to Expand Cancer AP Menu

Orchid Cellmark Wins $30 Million Forensic Testing Contract in U.K.

Lab Stocks Continue to Post Gains in May, up 8% Over 5 Weeks

Economic Development Incentives Fuel Genzyme Genetics’s Staff Expansion in Santa Fe